Swasti Urology & Nephrology Super Speciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 11-12-2024
- Revenue %
(FY 2022)
- Profit 45.49%
(FY 2022)
- Ebitda 85.27%
(FY 2022)
- Net Worth -13.80%
(FY 2022)
- Total Assets -23.61%
(FY 2022)
About Swasti Urology & Nephrology Super Speciality Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Madaiah Madegowda, Bangalore Gowda, Raghunath Krishnappa, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900KA2015PTC080106
- Company No.
080106
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Swasti Urology & Nephrology Super Speciality Hospitals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghunath Krishnappa  | Director | 05-May-2015 | Current |
| Madaiah Madegowda | Director | 05-May-2015 | Current |
| Bangalore Gowda | Director | 05-May-2015 | Current |
| Narasimha Srivatsa | Director | 05-May-2015 | Current |
Financial Performance and Corporate Structure Insights of Swasti Urology & Nephrology Super Speciality Hospitals.
Swasti Urology & Nephrology Super Speciality Hospitals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 45.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swasti Urology & Nephrology Super Speciality Hospitals?
In 2019, Swasti Urology & Nephrology Super Speciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bangalore West Urologists Private LimitedActive 11 years 3 monthsMadaiah Madegowda and Bangalore Gowda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Oct 2015 | ₹4.00 M | Open |
How Many Employees Work at Swasti Urology & Nephrology Super Speciality Hospitals?
Unlock and access historical data on people associated with Swasti Urology & Nephrology Super Speciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swasti Urology & Nephrology Super Speciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swasti Urology & Nephrology Super Speciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
